Argus raised the price target for the Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) stock from “a Buy” to “a Hold”. The rating was released on March 02, 2021. The research report from JP Morgan has downgraded the stock from Neutral to Underweight, with a price target set at $11. The stock was downgraded by Robert W. Baird, who disclosed in a research note on October 19, 2020, from Outperform to Neutral and set the price objective to $13. In their research brief published July 21, 2020, Goldman analysts downgraded the Allscripts Healthcare Solutions Inc. stock from Neutral to Sell with a price target of $5.50.
Historical Earnings Surprises and Revenue Forecasts
Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price to increase when earnings exceed market expectations and progressively decrease when earnings do not meet expectations. The firm reported an earnings per share (EPS) of $0.29 during the last quarter as opposed to a consensus estimate of $0.21, which indicates the company beat its estimate by $0.08, which implies that the company surprised the market by 38.10%. It appears that the average earnings per share estimate for the current quarter (ending in Mar 2021) is $0.15. This is an average of 15 analysts’ earnings, where the high earnings per share estimate is $0.2 and the low earnings per share estimate is $0.11. According to 12 analyst estimates, an average revenue estimate of $368.66M is projected for the current quarter with a high revenue estimate of $375.2M and a low estimate of $363.69M.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) raised 0.99% to close Friday’s market session at $16.34, higher as compared to yesterday’s close. The stock price fluctuated between $16.19 and $16.505 throughout the trading session with the volume trading being 1303306 shares, which represented a significant variation when compared to the three months average volume of 2.10 million shares. The firm’s stock price fluctuated 3.94% within the last five trades and 8.79% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 48.41% in the last 6 months and -4.00% was subtracted to its value over the previous 3 months. MDRX stock is trading at a margin of 5.52%, 4.15% and 31.68% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
As of the close of trading, MDRX deals in the Healthcare domain. The stock is trading -9.02 percent below its 52-week high and 209.47 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 118.59. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does Allscripts Healthcare Solutions Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at -8.80 percent and the profit margin is 46.60 percent, and the company has reported a gross margin of 37.60 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $2.31 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 20.55. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1.53 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 1.48, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Black Paul, the CEO at Allscripts Healthcare Solutions Inc. (MDRX) has sold 60,000 shares of firm on Mar 15 at a price of $15.72 against the total amount of $0.94 million. In another inside trade, Khorey Lisa, Chief Client Delivery Officer of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) sold 15,000 shares of the firm on Feb 18 for a total worth of $0.25 million at a price of $16.75. An inside trade which took place on Dec 14, CEO of Allscripts Healthcare Solutions Inc. Black Paul sold 60,000 shares of firm against total price of $0.84 million at the cost of $14.03 per share.